Synthesis and Structure−Activity Relationships of Naphthamides as Dopamine D3 Receptor Ligands-Reference-Cited by-同舟云学术

Synthesis and Structure−Activity Relationships of Naphthamides as Dopamine D3 Receptor Ligands

Published:2001-03-31 Issue:11 Volume:44 Page:1815-1826
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Huang Yunsheng¹,Luedtke Robert R.¹,Freeman Rebekah A.¹,Wu Li¹,Mach Robert H.¹

Affiliation:

1. Department of Radiology-PET Center and Department of Physiology & Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, and Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0100077

Reference44 articles.

1. Synergistic Interactions of D1- and D2-Selective Dopamine Agonists in Animal Models for Parkinson’s Disease: Sites of Action and Implications for the Pathogenesis of Dyskinesias

2. Clozapine

3. Dopamine receptors: Molecular biology, biochemistry and behavioural aspects

4. Dopamine Receptors: From Structure to Function

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases;Bioorganic & Medicinal Chemistry;2024-08

2. In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor;Frontiers in Neuroscience;2024-04-09

3. Exploring the Pivotal Role of Pyrrolidine Ring in Search of Multipotent Agents in Neurodegenerative Diseases;2024

4. Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D2 and D3 receptors;European Journal of Medicinal Chemistry;2023-12

5. Efecto del 2-aminoindano rígido, derivado del acenafteno, sobre la conducta estereotipada de ratas. Papel del sistema dopaminérgico cerebral;Investigación Clínica;2020-09